Cargando…

Protective immunity by an engineered DNA vaccine for Mayaro virus

Mayaro virus (MAYV) of the genus alphavirus is a mosquito-transmitted emerging infectious disease that causes an acute febrile illness, rash, headaches, and nausea that may turn into incapacitating, persistent arthralgias in some victims. Since its discovery in Trinidad in 1954, cases of MAYV infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Hyeree, Kudchodkar, Sagar B., Reuschel, Emma L., Asija, Kanika, Borole, Piyush, Ho, Michelle, Wojtak, Krzysztof, Reed, Charles, Ramos, Stephanie, Bopp, Nathen E., Aguilar, Patricia V., Weaver, Scott C., Kim, J. Joseph, Humeau, Laurent, Tebas, Pablo, Weiner, David B., Muthumani, Kar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366747/ https://www.ncbi.nlm.nih.gov/pubmed/30730897 http://dx.doi.org/10.1371/journal.pntd.0007042

Ejemplares similares

Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge
por: Choi, Hyeree, et al.
Publicado: (2019)

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics
por: Khoshnejad, Makan, et al.
Publicado: (2019)

In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus
por: Esquivel, Rianne N., et al.
Publicado: (2019)

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus
por: Choi, Hyeree, et al.
Publicado: (2020)

Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
por: Kudchodkar, Sagar B., et al.
Publicado: (2018)

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection
por: Tebas, Pablo, et al.
Publicado: (2017)

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)

Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody
por: Zankharia, Urvi S., et al.
Publicado: (2020)

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity
por: Shedlock, Devon J., et al.
Publicado: (2014)

IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment
por: Perales-Puchalt, Alfredo, et al.
Publicado: (2018)

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
por: Muthumani, Kar, et al.
Publicado: (2017)

Multivalent DNA Vaccines as a Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses
por: Jiang, Jingjing, et al.
Publicado: (2021)

Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model
por: Louis, Lumena, et al.
Publicado: (2019)

436. Developing a Synthetic DNA Vaccine for an Emerging Pathogen - Middle East Respiratory Syndrome
por: Reuschel, Emma L., et al.
Publicado: (2016)

In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine
por: Muthumani, Karuppiah, et al.
Publicado: (2016)

Hunting in the Rainforest and Mayaro Virus Infection: An emerging Alphavirus in Ecuador
por: Izurieta, Ricardo O, et al.
Publicado: (2011)

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
por: Chung, Christopher, et al.
Publicado: (2023)

Family Cluster of Mayaro Fever, Venezuela
por: Torres, Jaime R., et al.
Publicado: (2004)

Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth
por: Wojtak, Krzysztof, et al.
Publicado: (2019)

Mayaro: an emerging viral threat?
por: Acosta-Ampudia, Yeny, et al.
Publicado: (2018)

Mouse Models of Mayaro Virus
por: Rosa, Rafael Borges, et al.
Publicado: (2023)

In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease
por: Mota, Mânlio Tasso de Oliveira, et al.
Publicado: (2020)

Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors
por: Langendries, Lana, et al.
Publicado: (2021)

DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond
por: Maslow, Joel N., et al.
Publicado: (2023)

Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation
por: Schommer, Nina N., et al.
Publicado: (2019)

A Novel Live-Attenuated Vaccine Candidate for Mayaro Fever
por: Weise, William J., et al.
Publicado: (2014)

Mayaro Fever Virus, Brazilian Amazon
por: Azevedo, Raimunda S.S., et al.
Publicado: (2009)

Mayaro Virus Pathogenesis and Transmission Mechanisms
por: Diagne, Cheikh Tidiane, et al.
Publicado: (2020)

Mayaro virus in Latin America and the Caribbean
por: Ganjian, Niloofar, et al.
Publicado: (2020)

Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig
por: Xu, Ziyang, et al.
Publicado: (2018)

Mayaro virus pathogenesis and immunity in rhesus macaques
por: Weber, Whitney C., et al.
Publicado: (2023)

HIV-1 Env DNA Vaccine plus Protein Boost Delivered by EP Expands B- and T-Cell Responses and Neutralizing Phenotype In Vivo
por: Muthumani, Kar, et al.
Publicado: (2013)

SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients
por: Walker, Susanne N., et al.
Publicado: (2020)

Mayaro Virus Infection, Amazon Basin Region, Peru, 2010–2013
por: Halsey, Eric S., et al.
Publicado: (2013)

Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential
por: Webb, Emily M., et al.
Publicado: (2019)

Mayaro Virus in Wild Mammals, French Guiana
por: de Thoisy, Benoît, et al.
Publicado: (2003)

Neutralising antibodies for Mayaro virus in Pantanal, Brazil
por: Pauvolid-Corrêa, Alex, et al.
Publicado: (2015)

Favipiravir Inhibits Mayaro Virus Infection in Mice
por: Bengue, Michèle, et al.
Publicado: (2021)

Mayaro Virus: The Potential Role of Microbiota and Wolbachia
por: Pereira, Thiago Nunes, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ae9jq7o01hmllhq1i45pifrp1p